Evidence map›Paper›PMID 42485524›Full record

SynthesisJournal of food and drug analysis2026

Effect of cosmetic whitening ingredients' lipophilicity on melanocyte cytotoxicity: A systematic review.

Lord Sam B Liston, Zach Uriel Cabije, Enrico John Belleza, Catherine Ortega, Mark Niño Melgo, Vanbeth Camson, Sabrina Dahlizar, Pajaree Sakdiset, Gea Abigail Ecoy, Gerard Lee See and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of food and drug analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lord Sam B ListonDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Zach Uriel CabijeDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Enrico John BellezaDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Catherine OrtegaDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Mark Niño MelgoDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Vanbeth CamsonDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Sabrina DahlizarDepartment of Pharmacy, Faculty of Health Science, Syarif Hidayatullah State Islamic University Jakarta, Banten, 15419, Indonesia.
Pajaree SakdisetDrug and Cosmetics Excellence Center, Walailak University, Thasala, Nakhon Si Thammarat, 80161, Thailand.
Gea Abigail EcoyDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Gerard Lee SeeDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.
Florencio ArceDepartment of Pharmacy, School of Health Care Professions, University of San Carlos, Nasipit, Talamban, Cebu, 6000, Republic of the Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinase is an enzyme involved in the early stages of melanin synthesis. Melanin, which gives skin its pigment, is the most targeted molecule in the development of skin-whitening cosmetic products. Consequential risks of chemically induced skin diseases are associated with the usage of skin-whitening products that contain tyrosinase-inhibiting compounds. Currently, products containing tyrosinase inhibitors on the market lack collective analysis of their toxicity on melanocytes. Moreover, national regulatory agencies (e.g., FDA) place the burden of ensuring the safety of whitening products on manufacturers, risking bias and selective reporting. In fact, the ASEAN Cosmetic Directive does not include more than half of the 'novel' whitening agents currently on the market. This review describes the relationship of lipophilicity of cosmetic whitening ingredients (CWI) with melanocyte cytotoxicity. A systematic search of databases using the phrase (((Skin Whitening) OR (Skin Brightening) OR (Skin Lightening) OR (Skin Bleaching)) AND ((Melanocyte Cytotoxicity) OR (Cytotoxicity) OR (Cytotoxic Effect)) AND Mechanism)) was carried out. Data such as the assay and medium used, mechanism of action, cLogP, and cell viability were extracted from the 11 articles in the study. The cell viability data and respective concentration used for the MTT assays were used to calculate the IC50 values of each CWI using the drc-R package in R. The identified CWIs were categorized by their respective lipophilicity; subsequently, linear regression analysis was conducted. It was revealed that the cLogP of the CWIs was able to exhibit a moderate positive correlation between IC50 values (R

Indexed as

CosmeticsMelanocytesSkin Lightening PreparationsAnimalsCell SurvivalHumansHydrophobic and Hydrophilic InteractionsMelaninsMonophenol MonooxygenaseCosmeticsMelaninsMonophenol MonooxygenaseSkin Lightening Preparations

Identifiers

PMID42485524
PMCPMC13391007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.